& Actual Exam Preparation: High-Yield Questions with
Complete Verified Solutions
MODULE 1: High-Yield Antibody & Resolution Patterns (Q1-15)
Q1: A patient's antibody screen is positive. Panel shows:
● 3+ reactions with all cells at IS, 37°C, and AHG phases.
● Autocontrol: 4+ at all phases.
● Eluate: Reactive with all panel cells.
DTT treatment of patient cells prior to autocontrol: Negative.
● What is the MOST appropriate immediate action to find compatible blood?
A) Perform a warm autoadsorption.
B) Perform a cold autoadsorption.
C) Perform an alloadsorption with R1R1 and R2R2 cells.
D) Type the patient for high-frequency antigens and initiate a rare donor search.
Correct Answer: B
COMPLETE SOLUTION (Coaching Moment):
● Pattern Recognition Cue: This is a classic cold autoantibody pattern: strong
reactions at all phases including IS, strongly positive autocontrol, panreactive
eluate. The key confirming clue is the negative DTT-treated autocontrol (DTT
denatures the IgM cold autoantibody).
● Two-Path Review:
○ Quick Correct Path: Recognize cold autoantibody → Perform cold
autoadsorption (using patient's own RBCs treated with ZZAP or at 4°C) to
remove the cold autoantibody from the serum → Test adsorbed serum for
underlying alloantibodies.
○ Long Incorrect Path: Misinterpreting the panreactivity as a warm
autoantibody or alloantibody → Attempting warm autoadsorption (A) or
, alloadsorption (C), which would be inefficient or waste rare cells →
Delaying transfusion.
● Test-Taking Tip: "Cold = Cold Adsorption. Warm = Warm Adsorption." Strong IS
phase reactivity points to cold antibody.
● Memory Anchor: Picture an ice cube (cold) next to the letters "IS" (Immediate
Spin).
● If You Missed This: Re-review the serologic differentiation of warm vs. cold
autoantibodies and the principles of autoadsorption in the AABB Technical
Manual, Chapter 19.
Q2: An eluate from a DAT-positive neonate shows anti-D specificity. The mother is group
A, Rh-negative with anti-D (titer 128). The baby is group A, Rh-positive with a strongly
positive DAT. The father is phenotyped as Rh-negative. What is the most likely
explanation?
A) The father has a D variant not detected by standard typing.
B) This is a case of false-positive eluate due to DAT reagent carryover.
C) The baby received an intrauterine transfusion with D-positive blood.
D) The mother has anti-A causing the positive DAT.
Correct Answer: A
COMPLETE SOLUTION (Coaching Moment):
● Pattern Recognition Cue: This is the "D-negative father" paradox in HDFN. When
anti-D appears in the baby but the father types as D-negative, think D variant
(weak D, partial D, or mosaicism).
● Two-Path Review:
○ Quick Correct Path: Father phenotyped as Rh-negative but baby is clearly
D-positive (anti-D in eluate, positive DAT) → Father must carry a D variant
undetected by standard serology (e.g., weak D type 1, 2, 3 or partial D) →
Mother immunized by pregnancy/transfusion → Baby affected.
○ Long Incorrect Path: Assuming laboratory error (B) or focusing only on the
ABO group (D) while missing the critical Rh discrepancy.
● Test-Taking Tip: "D-negative father + D-positive baby = D variant in father." Always
consider genetic variants when serology doesn't match pedigree.
● Memory Anchor: "Dad's Deception" – Dad looks D-negative but hides a variant.
, ● If You Missed This: Review Rh genetics, weak D types, and the concept of partial
D causing immunization.
Q3: A panel shows the following pattern:
● Reacts with: R1R1 (CDe/CDe), R2R2 (cDE/cDE), rr (cde/cde)
Does NOT react with: r'r (Cde/Cde), r"r (cDE/cde)
● The antibody is most likely:
A) Anti-e
B) Anti-f (ce)
C) Anti-C
D) Anti-D
Correct Answer: B
COMPLETE SOLUTION (Coaching Moment):
● Pattern Recognition Cue: This is "anti-f exclusion logic." Anti-f is an antibody to
the compound antigen "ce" (present when c and e are inherited together in cis).
● Two-Path Review:
○ Quick Correct Path: Anti-f reacts with R1R1 (has Ce, not ce), R2R2 (has cE,
not ce), and rr (has ce). It does NOT react with r'r (Cde - has c but not e
together) or r"r (cDE - has c but not e). This matches the pattern.
○ Long Incorrect Path: Guessing anti-e (A) which would react with rr and r'r,
or anti-C (C) which would react with r'r. Systematically check each cell's
genotype against the pattern.
● Test-Taking Tip: "Anti-f = anti-ce." It requires both c and e on the same
chromosome. Remember: rr has ce (reacts), r'r has c but with e? No, r'r is Cde
(reacts? No, f is ce).
● Memory Anchor: "f = father of ce" – f only exists when c and e are together (like
parents together).
● If You Missed This: Review compound antigens (f, ce; r做成, Ce; Rh29, total Rh)
and cis-trans effects in the Rh system.
, Q4: A patient with SCD has anti-C and anti-e identified. You perform phenotyping and
find the patient is C-negative, c-positive, E-negative, e-positive. You need to select blood.
Which combination is BEST?
A) C-negative, c-positive, E-negative, e-positive
B) C-negative, c-positive, E-positive, e-positive
C) C-positive, c-negative, E-negative, e-positive
D) C-negative, c-negative, E-negative, e-positive
Correct Answer: D
COMPLETE SOLUTION (Coaching Moment):
● Pattern Recognition Cue: This tests antigen-matching in SCD beyond just
antibody avoidance. The patient is C-, c+, E-, e+ (likely R0r or R1r, but specifically
CcEe). They have anti-C and anti-e.
● Two-Path Review:
○ Quick Correct Path: Patient has anti-C → need C-negative. Patient has
anti-e → need e-negative. Look for C-negative AND e-negative. Option D is
C-negative, c-negative, E-negative, e-negative (rr or "double negative"). This
is the safest.
○ Long Incorrect Path: Selecting A (matches patient phenotype) but
forgetting that homozygous expression reduces risk of antibodies to
altered forms. Or selecting B (E-positive) which risks anti-E. Or selecting C
(C-positive) which definitely risks reaction.
● Test-Taking Tip: "When in doubt, go homozygous negative." rr (ccee) blood is the
"universal donor" for Rh in SCD patients because it lacks C, E, and the complex
antigens.
● Memory Anchor: "RR for SCD = Really Rare, Really Required." (Meaning
Rh-matched, specifically R0 or R1/R2 negative).
● If You Missed This: Review SCD extended matching protocols (C, E, K matching
plus antibody considerations) and the significance of Rh phenotype matching.
Q5: An antibody screen shows pan-reactivity at AHG phase only. Autocontrol is
negative. Enzyme (ficin) treatment of panel cells: all reactions negative. What is the
specificity?